CASI Pharmaceuticals
CASI
#10786
Rank
A$6.07 M
Marketcap
A$0.30
Share price
0.00%
Change (1 day)
-85.89%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -A$73.7 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$26.84 Million. In 2024 the company made an earning of -A$54.28 Million a decrease over its 2023 earnings that were of -A$37.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.7 Million35.79%
2024 -A$54.28 Million44.35%
2023 -A$37.6 Million-29.55%
2022 -A$53.37 Million4.43%
2021 -A$51.1 Million-24.56%
2020 -A$67.74 Million4.74%
2019 -A$64.68 Million65.13%
2018 -A$39.17 Million155.07%
2017 -A$15.36 Million13.93%
2016 -A$13.48 Million31.18%
2015 -A$10.28 Million-72.5%
2014 -A$37.36 Million356.62%
2013 -A$8.19 Million-60.55%
2012 -A$20.74 Million218.41%
2011 -A$6.52 Million0.74%
2010 -A$6.47 Million-32.54%
2009 -A$9.59 Million-66.98%
2008 -A$29.03 Million-14.22%
2007 -A$33.84 Million7.04%
2006 -A$31.61 Million27.95%
2005 -A$24.71 Million4.51%
2004 -A$23.64 Million-15.84%
2003 -A$28.09 Million-55.29%
2002 -A$62.83 Million-34.05%
2001 -A$95.26 Million31.73%
2000 -A$72.31 Million31.56%
1999 -A$54.97 Million145.56%
1998 -A$22.39 Million76.4%
1997 -A$12.69 Million36.92%
1996 -A$9.27 Million